Discussion Replay: Patient Advisory Boards in Clinical Research: Why and How
Patient engagement is becoming more critical than ever in successfully conducting clinical research for a drug or device in addressing patient needs and optimizing registration and reimbursement.
The Patient Advisory Board is a key step to adequately engaging patients in product development. Engaging these patient experts can result in better quality research and encourage decision-makers and researchers to utilize patients’ valuable input to inform clinical study protocols and ultimately enhance patient recruitment and outcomes.
Watch the recording of this unique roundtable discussion and discuss the best practices around planning, setting up, and managing your Patient Advisory Board alongside the leading industry experts.
What you will learn
- What is the ideal time to set up a Patient Advisory Board in clinical research
- What are the best practices in the setup and management of your Patient Advisory Board
- How to incorporate the learnings from Patient Advisory Board to the clinical trial protocol and study conduct
Meet the roundtable discussion participants
Philippe Picaut – Chief Scientific Officer, AlgoTherapeutix
Philippe is currently Chief Scientific Officer in a start-up company, AlgoTherapeutix, which aims at developing new products in complex chronic pain indications. Philippe led interdisciplinary/ international teams in different Therapeutic Areas through all phases of development including the registration of major products in the EU, USA, and Japan within six different pharmaceutical companies, Rhône-Poulenc, Rhône-Poulenc Rorer, Aventis, Pierre Fabre, Ipsen, and AlgoTherapeutix. Philippe is the co-author of more than 30 publications.
Annabel De Maria – Vice President, Patient Engagement, Alira Health
As Patient Engagement expert, Annabel has 24 years of experience in the field of pharma and medtech. Since the start of her career, she has worked as Patient Brand Manager and Head of Communications in such companies as Pfizer, Bayer, Novartis Spain, and Nestlé Purina until she joined Alira Health in October 2020, she teaches at the Barcelona Biotechnology Institute about patient engagement, and she volunteers at the Rare Diseases Department at the Hospital Clinic of Barcelona.
The discussion will be moderated by Giulia Pierini, Consultant, Patient Engagement of Alira Health.